Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis

Trial Profile

Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis

Withdrawn prior to enrolment
Phase of Trial: Phase I/II

Latest Information Update: 02 May 2017

At a glance

  • Drugs Cord blood stem cell therapy (Primary) ; Cord blood stem cell therapy (Primary)
  • Indications Osteoarthritis
  • Focus Adverse reactions
  • Sponsors Translational Biosciences
  • Most Recent Events

    • 26 Apr 2017 Status changed from active, no longer recruiting to withdrawn prior to enrolment.
    • 17 Oct 2016 Planned End Date changed from 1 Mar 2017 to 1 Aug 2019.
    • 17 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Nov 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top